Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Current evidence highlights the need for appropriate diagnosis and therapy to improve outcomes in people with mild autonomous cortisol secretion (MACS). We aimed to validate the clinical sex-specific significance of the novel diagnosis MACS by characterizing patients according to morbidity and mortality in a real-world setting. Methods This retrospective single-center cohort study included clinical data from 670 adult patients with adrenal adenomas undergoing diagnostic workup regarding adrenal hypercortisolism at the Vienna General Hospital from 01.01.2000 to 31.12.2022. For mortality analyses, follow-up data spanning over 20 years was available, patients alive after 01.12.2024 were censored. Patients were classified into 3 groups based on post 1mg-DST cortisol levels (≤1.8µg/dL (suppressed 1mg-DST); >1.8 to ≤5µg/dl (mildly elevated 1mg-DST); >5µg/dL (markedly elevated 1mg-DST)) and analyzed according to cortisol-associated morbidity and mortality. Results Compared to those with suppressed 1mg-DST, patients with mildly elevated 1mg-DST were more frequently diagnosed with cortisol-associated diseases like cardiovascular disease (CVD) and osteoporosis while patients with markedly elevated 1mg-DST had more frequently arterial hypertension (aHTN) and osteoporosis, particularly women. Patients with mildly elevated 1mg-DST exhibited the highest mortality, despite comparable prevalence rates of cortisol-associated comorbidities between the mildly and the markedly elevated 1mg-DST group, even after adjusting for age, sex, BMI and cardiometabolic risk factors (HR 1.57 ( 95% CI: 1.01-2.45)). This was attenuated after additional adjustment for cancer history. Conclusion We identified the mildly elevated 1mg-DSTgroup as a high-risk formerly overlooked cohort, characterized by increased morbidity and mortality. Further prospective studies are needed to clarify the underlying mechanisms and the potential role of cortisol-specific treatment.
Source: Frontiers in Endocrinology
Authors: Luise Bellach(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing), Dorota Sluková(Data curation, Writing – original draft, Writing – review & editing), Dorothea Kalender(Data curation, Writing – original draft, Writing – review & editing), Sarah Hofer-Zeni(Writing – original draft, Writing – review & editing), Liliana Gard(Data curation, Writing – original draft, Writing – review & editing), Sabina Baumgartner-Parzer(Resources, Supervision, Writing – original draft, Writing – review & editing), Rodrig Marculescu(Resources, Supervision, Writing – original draft, Writing – review & editing), Greisa Vila(Conceptualization, Supervision, Writing – original draft, Writing – review & editing), Peter Wolf(Supervision, Writing – original draft, Writing – review & editing), Alexandra Kautzky-Willer(Conceptualization, Resources, Supervision, Writing – original draft, Writing – review & editing), Michael Leutner(Conceptualization, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing)
Institution: Medical University of Vienna
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234123244
